These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 21356152)

  • 1. Cytochrome P450 eicosanoids and cerebral vascular function.
    Imig JD; Simpkins AN; Renic M; Harder DR
    Expert Rev Mol Med; 2011 Mar; 13():e7. PubMed ID: 21356152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 eicosanoids are activators of peroxisome proliferator-activated receptor alpha.
    Ng VY; Huang Y; Reddy LM; Falck JR; Lin ET; Kroetz DL
    Drug Metab Dispos; 2007 Jul; 35(7):1126-34. PubMed ID: 17431031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
    Huang H; Al-Shabrawey M; Wang MH
    Prostaglandins Other Lipid Mediat; 2016 Jan; 122():45-53. PubMed ID: 26747234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epoxyeicosatrienoic Acids and 20-Hydroxyeicosatetraenoic Acid on Endothelial and Vascular Function.
    Imig JD
    Adv Pharmacol; 2016; 77():105-41. PubMed ID: 27451096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of cytochrome P450-dependent arachidonic acid metabolites in liver physiology and pathophysiology.
    Sacerdoti D; Gatta A; McGiff JC
    Prostaglandins Other Lipid Mediat; 2003 Oct; 72(1-2):51-71. PubMed ID: 14626496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel role for P450 eicosanoids in the neurogenic control of cerebral blood flow in the rat.
    Iliff JJ; Close LN; Selden NR; Alkayed NJ
    Exp Physiol; 2007 Jul; 92(4):653-8. PubMed ID: 17639071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epoxyeicosatrienoic acids, 20-hydroxyeicosatetraenoic acid, and renal microvascular function.
    Imig JD
    Prostaglandins Other Lipid Mediat; 2013; 104-105():2-7. PubMed ID: 23333581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease.
    Theken KN; Schuck RN; Edin ML; Tran B; Ellis K; Bass A; Lih FB; Tomer KB; Poloyac SM; Wu MC; Hinderliter AL; Zeldin DC; Stouffer GA; Lee CR
    Atherosclerosis; 2012 Jun; 222(2):530-6. PubMed ID: 22503544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epoxyeicosanoids as mediators of neurogenic vasodilation in cerebral vessels.
    Iliff JJ; Wang R; Zeldin DC; Alkayed NJ
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1352-63. PubMed ID: 19304946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of EETs and HETE-generating cytochrome P-450 enzymes and the effects of their metabolites on myometrial and vascular function.
    Pearson T; Warren AY; Barrett DA; Khan RN
    Am J Physiol Endocrinol Metab; 2009 Sep; 297(3):E647-56. PubMed ID: 19549792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of cytochrome P450 metabolites of arachidonic acid by stable isotope probe labeling coupled with ultra high-performance liquid chromatography/mass spectrometry.
    Zhu QF; Hao YH; Liu MZ; Yue J; Ni J; Yuan BF; Feng YQ
    J Chromatogr A; 2015 Sep; 1410():154-63. PubMed ID: 26253834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450-derived eicosanoids and vascular dysfunction in coronary artery disease patients.
    Schuck RN; Theken KN; Edin ML; Caughey M; Bass A; Ellis K; Tran B; Steele S; Simmons BP; Lih FB; Tomer KB; Wu MC; Hinderliter AL; Stouffer GA; Zeldin DC; Lee CR
    Atherosclerosis; 2013 Apr; 227(2):442-8. PubMed ID: 23466098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 20-Hydroxyeicosatetraenoic Acid Inhibition by HET0016 Offers Neuroprotection, Decreases Edema, and Increases Cortical Cerebral Blood Flow in a Pediatric Asphyxial Cardiac Arrest Model in Rats.
    Shaik JS; Poloyac SM; Kochanek PM; Alexander H; Tudorascu DL; Clark RS; Manole MD
    J Cereb Blood Flow Metab; 2015 Nov; 35(11):1757-63. PubMed ID: 26058691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal vascular cytochrome P450-derived eicosanoids in androgen-induced hypertension.
    Singh H; Schwartzman ML
    Pharmacol Rep; 2008; 60(1):29-37. PubMed ID: 18276983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient Mice.
    Zhu Y; Blum M; Hoff U; Wesser T; Fechner M; Westphal C; Gürgen D; Catar RA; Philippe A; Wu K; Bubalo G; Rothe M; Weldon SM; Dragun D; Schunck WH
    PLoS One; 2016; 11(1):e0145645. PubMed ID: 26727266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytochrome P450 eicosanoids in hypertension and renal disease.
    Fan F; Muroya Y; Roman RJ
    Curr Opin Nephrol Hypertens; 2015 Jan; 24(1):37-46. PubMed ID: 25427230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arachidonic acid cytochrome P450 epoxygenase pathway.
    Spector AA
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S52-6. PubMed ID: 18952572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased epoxyeicosatrienoic acids and reduced soluble epoxide hydrolase expression in the preeclamptic placenta.
    Dalle Vedove F; Fava C; Jiang H; Zanconato G; Quilley J; Brunelli M; Guglielmi V; Vattemi G; Minuz P
    J Hypertens; 2016 Jul; 34(7):1364-70. PubMed ID: 27115337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 pathways of arachidonic acid metabolism.
    Kroetz DL; Zeldin DC
    Curr Opin Lipidol; 2002 Jun; 13(3):273-83. PubMed ID: 12045397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epoxyeicosatrienoates are the dominant eicosanoids in human lungs upon microbial challenge.
    Kiss L; Schütte H; Padberg W; Weissmann N; Mayer K; Gessler T; Voswinckel R; Seeger W; Grimminger F
    Eur Respir J; 2010 Nov; 36(5):1088-98. PubMed ID: 20378604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.